Last reviewed · How we verify
NCT07420556
Effect of Different HPV Education Methods on Vaccination Intention in Young Women
NA trial testing Video-Based HPV Education in Human Papillomavirus (HPV) Infection in 117 participants. Currently enrolling.
15 January 2026
Quick facts
| Lead sponsor | Emel GÜÇLÜ CİHAN |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 117 |
| Start date | 15 December 2025 |
| Primary completion | 15 January 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Video-Based HPV Education
- Face-to-Face HPV Education
- Video-Based HPV Education
- Face-to-Face HPV Education
Conditions studied
- Human Papillomavirus (HPV) Infection — all drugs for Human Papillomavirus (HPV) Infection →
- HPV Vaccination Acceptance/Intention — all drugs for HPV Vaccination Acceptance/Intention →
Sponsor
Emel GÜÇLÜ CİHAN
Who can join
Adults 18 to 24, female only, with Human Papillomavirus (HPV) Infection or HPV Vaccination Acceptance/Intention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention. The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years. The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group. Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained. Research Questions Does HPV education delivered through different methods increase HPV knowledge levels among young women? Does HPV education increase HPV vaccination intention compared with the control group? Is face-to-face education more effective than video-based education in increasing vaccination intention? Are the improvements in knowledge and vaccination intention sustained one month after the education?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07420556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Human Papillomavirus (HPV) Infection
Currently open trials in the same condition.
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
- NCT07275333 — Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine · NA · recruiting
Other Emel GÜÇLÜ CİHAN trials
Trials by the same sponsor.
- NCT07478341 — Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07420556 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Emel GÜÇLÜ CİHAN
- Last refreshed: 19 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07420556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing